beta-alanine and salmeterol xinafoate

beta-alanine has been researched along with salmeterol xinafoate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Austin, RP; Bonnert, R; Cadogan, E; Connolly, S; Gardiner, P; Jordan, S; Lawson, M; Nicholls, DJ; Paine, SW; Young, A	1

Other Studies

1 other study(ies) available for beta-alanine and salmeterol xinafoate

Article	Year
Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action. Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:4 Topics: Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Benzothiazoles; beta-Alanine; Blood Proteins; Bronchi; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Guinea Pigs; Humans; Male; Muscle Relaxation; Protein Binding; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Time Factors	2012

Article

Year

Characteristics of AZD9708, a novel, selective β2-adrenoceptor agonist with rapid onset and long duration of action.

Pulmonary pharmacology & therapeutics, 2012, Volume: 25, Issue:4

Topics: Adenosine Monophosphate; Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthma; Benzothiazoles; beta-Alanine; Blood Proteins; Bronchi; Bronchodilator Agents; Ethanolamines; Formoterol Fumarate; Guinea Pigs; Humans; Male; Muscle Relaxation; Protein Binding; Pulmonary Disease, Chronic Obstructive; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Time Factors

2012